This HTML5 document contains 137 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n8http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n13https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33365226
rdf:type
wikibase:Item
schema:description
2005年论文 teaduslik artikkel scientific article vědecký článek article scientific articolo scientifico מאמר מדעי article científic 2005年論文 tudományos cikk 2005年论文 научна статия наукова стаття, опублікована в березні 2005 article scientifique (publié 2005) vedecký článok სამეცნიერო სტატია tieteellinen artikkeli artikulong pang-agham 2005年论文 2005 nî lūn-bûn سائنسی مضمون บทความทางวิทยาศาสตร์ научни чланак artículu científicu espublizáu en 2005 2005年論文 wissenschaftlicher Artikel naučni članak 2005年論文 научни чланак 2005年论文 vitskapeleg artikkel научная статья επιστημονικό άρθρο mokslinis straipsnis scienca artikolo 2005年論文 2005년 논문 2005年の論文 2005 թվականի մարտին հրատարակված գիտական հոդված مقالة علمية ২০০৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ articol științific videnskabelig artikel (udgivet 2005) 2005年論文 bilimsel makale мақолаи илмӣ wetenschappelijk artikel artigo científico (publicado na 2005) 2005年论文 artykuł naukowy artigo científico 2005 թուականի Մարտին հրատարակուած գիտական յօդուած vitenskapelig artikkel vetenskaplig artikel мақолаи илмӣ مقالهٔ علمی bài báo khoa học artigo científico (publicado na 2005) artikull shkencor 2005年论文 artículo científico publicado en 2005
p:P577
wds:Q33365226-53FFDDCF-50E2-4970-B5D3-D85C3C1E452E
wdt:P577
2005-03-01T00:00:00Z
p:P2888
wds:Q33365226-4ECD1A26-B429-422F-99A6-B8F7A3EC0994
wdt:P2888
n13:s10637-005-5857-6
p:P2860
wds:Q33365226-B9F03FAE-27F4-4BC3-98D4-7353C56A5DC2 wds:Q33365226-EBFB9D64-1CEC-4C6F-AF2E-46AED6AD9112 wds:Q33365226-EC4367BB-7404-4E75-B2EC-46311DF65E0D wds:Q33365226-F219E742-61FF-42FF-B071-565FEE1F3527 wds:Q33365226-F35D8FAB-A8BD-49A2-AF74-69151BE26B79 wds:Q33365226-00BDB001-4F67-48B0-AA6B-323162317276 wds:Q33365226-16085585-DAD0-4A6B-97AA-DA2B934549FA wds:Q33365226-529AE7DA-3FA4-4AE8-BA46-0892A475012B wds:Q33365226-5399B900-E862-4682-8A06-2090509F90DB wds:Q33365226-62FB4A74-EF80-4BBF-ABD6-AD65DC499036 wds:Q33365226-751820A5-3C8A-424D-83BB-ABA06CB33330 wds:Q33365226-8562E77A-CCFE-41B3-8F4F-98108F19FCFA wds:Q33365226-A969F249-4107-4C26-8C84-FA7DEE008FE5 wds:Q33365226-B3BB26A5-4791-4B11-B618-E74F4DB48626
wdt:P2860
wd:Q33360707 wd:Q55478208 wd:Q28378015 wd:Q53970403 wd:Q41092388 wd:Q43578071 wd:Q70939350 wd:Q72892824 wd:Q69427024 wd:Q31066558 wd:Q69439323 wd:Q42213604 wd:Q43950121 wd:Q27860904
p:P2093
wds:Q33365226-BE55E8AF-3D66-44A3-92C7-46F14016BFB5 wds:Q33365226-A97A0112-A3EC-48BD-9498-EF1633B25500 wds:Q33365226-8EF4CCDE-56BE-416C-B0AB-753A2E8BF8AA wds:Q33365226-94E8744F-3591-4ACB-BDA3-427DD9DF58A7 wds:Q33365226-C9D2FA79-03BD-49BF-9AC0-9066568A67DF wds:Q33365226-732591CA-7EA4-4460-A542-5E6F03A09F99
wdt:P2093
Edward Chu Caroline Clairmont John Murren Shivaani Kummar Manuel Modiano Merrill Egorin
rdfs:label
A phase I and pharmacokinetic study of VNP40101M, a new alkylating agent, in patients with advanced or metastatic cancer A phase I and pharmacokinetic study of VNP40101M, a new alkylating agent, in patients with advanced or metastatic cancer A phase I and pharmacokinetic study of VNP40101M, a new alkylating agent, in patients with advanced or metastatic cancer
skos:prefLabel
A phase I and pharmacokinetic study of VNP40101M, a new alkylating agent, in patients with advanced or metastatic cancer A phase I and pharmacokinetic study of VNP40101M, a new alkylating agent, in patients with advanced or metastatic cancer A phase I and pharmacokinetic study of VNP40101M, a new alkylating agent, in patients with advanced or metastatic cancer
schema:name
A phase I and pharmacokinetic study of VNP40101M, a new alkylating agent, in patients with advanced or metastatic cancer A phase I and pharmacokinetic study of VNP40101M, a new alkylating agent, in patients with advanced or metastatic cancer A phase I and pharmacokinetic study of VNP40101M, a new alkylating agent, in patients with advanced or metastatic cancer
p:P50
wds:Q33365226-D0AEF967-30CD-4019-9B66-2DFE78B4107C
wdt:P50
wd:Q66809426
p:P1476
wds:Q33365226-6F70CAA7-BE10-4085-9C45-01740C065E97
wdt:P1476
A phase I and pharmacokinetic study of VNP40101M, a new alkylating agent, in patients with advanced or metastatic cancer
p:P304
wds:Q33365226-4F169312-3413-48B9-B2EB-306B1F4A2AA8
wdt:P304
123-135
p:P31
wds:Q33365226-6F0DFBA3-06DF-41B6-88A3-BB11464F6E78
wdt:P31
wd:Q13442814
p:P698
wds:Q33365226-E91A327C-6865-436F-A379-4A446164046D
wdtn:P698
n9:15744588
wdt:P698
15744588
p:P1433
wds:Q33365226-400EE37C-529C-4EAE-90BA-2A6D1C2C56DF
wdt:P1433
wd:Q2312231
p:P433
wds:Q33365226-827414BF-A70E-4810-A0D2-09C762E9AB3C
p:P478
wds:Q33365226-9856F5E2-95E7-458C-8CA7-A423082C702F
wdt:P433
2
wdt:P478
23
p:P356
wds:Q33365226-5E99E7CA-1C3C-4048-A167-336BF8697F47
wdtn:P356
n8:S10637-005-5857-6
wdt:P356
10.1007/S10637-005-5857-6
p:P6179
wds:Q33365226-17DED41A-4F28-4856-A0A8-AB4466AC7B86
wdt:P6179
1045954032